Ingrid A. Hedenfalk

Medicon Village
Lund, M 22381, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density.

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density.

Journal: Gynecologic oncology

Published: August 13, 2024

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

Journal: Cancer immunology, immunotherapy : CII

Published: June 05, 2024

Human proteome distribution atlas for tissue-specific plasma proteome dynamics.

Human proteome distribution atlas for tissue-specific plasma proteome dynamics.

Journal: Cell

Published: May 14, 2024

Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.

Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.

Journal: Human reproduction (Oxford, England)

Published: September 18, 2023

Molecular patterns of resistance to immune checkpoint blockade in melanoma.

Molecular patterns of resistance to immune checkpoint blockade in melanoma.

Journal: Nature communications

Published: July 27, 2023

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Journal: Molecular oncology

Published: July 11, 2023

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.

Journal: Nature communications

Published: May 08, 2023

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells.

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells.

Journal: Frontiers in immunology

Published: March 05, 2023

CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer.

CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer.

Journal: Cancers

Published: January 24, 2023

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer.

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer.

Journal: Computational and structural biotechnology journal

Published: October 14, 2022

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer.

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer.

Journal: Cancers

Published: July 04, 2022

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.

Journal: NPJ breast cancer

Published: January 26, 2022

Showing 1-12 of 59

Last Updated: 09/26/2026